We are live on ! Find out more
EVGN icon

Evogene

17 hedge funds and large institutions have $12M invested in Evogene in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

11% more capital invested

Capital invested by funds: $10.8M → $12M (+$1.23M)

6% more funds holding

Funds holding: 1617 (+1)

0.22% more ownership

Funds ownership: 2.62%2.84% (+0.22%)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$3.66M
WRF
2
Waddell & Reed Financial
Kansas
$3.23M
UBS Group
3
UBS Group
Switzerland
$1.6M -$18.7K -1,358 -1%
Goldman Sachs
4
Goldman Sachs
New York
$905K +$37.2K +2,700 +4%
CI
5
Clal Insurance
Israel
$698K +$813K +59,036 +65,596%
SM
6
Senvest Management
New York
$489K
Bank of America
7
Bank of America
North Carolina
$384K
MCM
8
Moon Capital Management
New York
$331K -$117K -8,506 -23%
PF
9
Phoenix Financial
Israel
$303K
AIM
10
ARK Investment Management
Florida
$302K +$39.8K +2,892 +13%
Jane Street
11
Jane Street
New York
$38K +$26.7K +1,938 +154%
MIH
12
Meitav Investment House
Israel
$23K
Wells Fargo
13
Wells Fargo
California
$20K +$23.4K +1,700 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$12K
Barclays
15
Barclays
United Kingdom
$1K
Citigroup
16
Citigroup
New York
-$12K -798 Closed
Osaic Holdings
17
Osaic Holdings
Arizona
+$28 +2 New

EVGN Hedge Fund Activity: Q1 2020 in Review

17 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q1 2020, worth a combined $12M — up 11% from $10.8M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EVGN positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Clal Insurance, adding an estimated $813K. The largest seller was Moon Capital Management, cutting an estimated $117K.

  • 17 institutional investors held Evogene (EVGN) as of Q1 2020, up from 16 in Q4 2019.
  • Funds reported $12M of Evogene stock for Q1 2020, up 11% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q1 2020 and 1 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q1 2020 was Clal Insurance, an estimated $813K added.
  • The largest Evogene seller in Q1 2020 was Moon Capital Management, an estimated $117K sold.

Based on aggregated 13F filings for Q1 2020.